HRMY

$32.475.65%-1.945

After Hours: 32.470.00 0.00%

Harmony Biosciences Holdings Inc (HRMY)

Harmony Biosciences Holdings Inc Stock (HRMY) Forecast

The Harmony Biosciences Holdings Inc (HRMY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $29.54, representing a -9.01% decrease from the current price of $32.47. The highest analyst price target is $34.26, and the lowest is $24.83.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month HRMY Price Target

Average 34.48 (+6.20% Downside)

Is Harmony Biosciences Holdings Inc (HRMY) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	27.06	Buy
STOCH(9,6)	52.76	Neutral
STOCHRSI(14)	43.73	Neutral
MACD(12,26)	-1.08	Sell
ADX(14)	30.28	Sell
William %R	-97.68	Buy
CCI(14)	-193.57	Sell

Buy: 2 · Sell: 3 · Neutral: 2Summary: Sell

Moving Averages

Period	Simple	Exponential
MA10	36.86 Sell	36.36 Sell
MA20	37.42 Sell	37.32 Sell
MA50	39.49 Sell	38.21 Sell
MA100	38.03 Sell	37.53 Sell
MA200	34.67 Sell	36.20 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, HRMY could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on HRMY, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 27.06 indicates that HRMY is oversold. This indicates that HRMY price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
STOCH (Stochastic Oscillator): The STOCH value of 52.76 indicates that HRMY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 43.73 indicates that HRMY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 30.28 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of -193.57 indicates that HRMY is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term HRMY price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Harmony Biosciences Holdings Inc financial reports and earnings history, Harmony Biosciences Holdings Inc (HRMY) stock could reach $32.97 by 2030, $11.75 by 2040 and $14.41 by 2050. See the projected annual prices until 2050 of the Harmony Biosciences Holdings Inc stock below:

Harmony Biosciences Holdings Inc (HRMY) is expected to reach an average price of $16.58 in 2035, with a high prediction of $24.33 and a low estimate of $10.38. This indicates an -48.95% change from the last recorded price of $32.47.
Harmony Biosciences Holdings Inc (HRMY) stock is projected to chart a bullish course in 2040, with an average price target of $4.97, representing an -84.69% change from its current level. The forecast ranges from a conservative $0.1469 to a sky-high $11.75.
Our analysts predict Harmony Biosciences Holdings Inc (HRMY) to change -87.11% by 2045, soaring from $0.1108 to an average price of $4.18, potentially reaching $23.94. While $0.1108 is the low estimate, the potential upside is significant.
Harmony Biosciences Holdings Inc (HRMY) stock is expected to climb by 2050, reaching an average of $3.87, a -88.07% change from its current level. However, a wide range of estimates exists, with high and low targets of $14.41 and $0.0658, respectively, highlighting the market's uncertainty.

Harmony Biosciences Holdings Inc Stock (HRMY) Year by Year Forecast

Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2026

The predicted value for Harmony Biosciences Holdings Inc (HRMY) in 2026 is set at an average of $33.58. Estimates vary from a peak of $43.49 to a trough of $23.72, indicating an +3.41% surge from the present price of $32.47.

Month	Average	Low	High	Change from today's price
December, 2026	$33.90	$24.83	$34.26	+4.39%

Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Harmony Biosciences Holdings Inc (HRMY) is $36.06, with a high forecast of $51.08 and a low forecast of $21.57. This indicates an +11.06% increase from the last price of $32.47.

Month	Average	Low	High	Change from today's price
January, 2027	$23.77	$23.64	$35.90	-26.80%
February, 2027	$27.02	$21.57	$29.74	-16.78%
March, 2027	$33.96	$24.53	$36.74	+4.59%
April, 2027	$40.11	$31.38	$42.88	+23.54%
May, 2027	$25.39	$24.80	$44.16	-21.79%
June, 2027	$33.81	$23.22	$34.97	+4.12%
July, 2027	$41.91	$31.37	$43.06	+29.07%
August, 2027	$41.30	$38.71	$47.39	+27.19%
September, 2027	$37.39	$35.49	$46.88	+15.16%
October, 2027	$37.35	$33.59	$38.81	+15.04%
November, 2027	$41.45	$32.20	$42.05	+27.67%
December, 2027	$49.27	$38.22	$51.08	+51.73%

Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2028

In 2028, Harmony Biosciences Holdings Inc (HRMY) is projected to reach an average price of $32.01, with a high projection of $52.55 and a low estimate of $20.42. This indicates an -1.42% fall from the last price of $32.47.

Month	Average	Low	High	Change from today's price
January, 2028	$50.94	$43.49	$51.98	+56.87%
February, 2028	$45.59	$44.26	$52.55	+40.40%
March, 2028	$39.09	$33.62	$46.10	+20.39%
April, 2028	$39.82	$36.79	$40.96	+22.65%
May, 2028	$32.51	$30.11	$41.31	+0.13%
June, 2028	$22.14	$20.42	$35.77	-31.83%
July, 2028	$25.68	$21.79	$28.08	-20.92%
August, 2028	$25.66	$24.51	$27.53	-20.98%
September, 2028	$24.16	$23.86	$28.25	-25.59%
October, 2028	$24.37	$22.28	$28.64	-24.94%
November, 2028	$27.05	$22.29	$27.26	-16.68%
December, 2028	$27.12	$23.68	$30.09	-16.49%

Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2029

The 2029 price forecast for Harmony Biosciences Holdings Inc Stock (HRMY) is $21.13 on average, with a high prediction of $27.92 and a low estimate of $9.47. This represents an -34.92% decrease from the previous price of $32.47.

Month	Average	Low	High	Change from today's price
January, 2029	$10.08	$9.47	$25.67	-68.97%
February, 2029	$17.88	$9.91	$18.18	-44.94%
March, 2029	$21.94	$18.02	$23.97	-32.43%
April, 2029	$22.30	$19.98	$25.46	-31.32%
May, 2029	$22.18	$21.38	$23.88	-31.68%
June, 2029	$23.15	$20.55	$26.42	-28.72%
July, 2029	$24.67	$20.42	$25.52	-24.04%
August, 2029	$20.44	$19.26	$25.17	-37.06%
September, 2029	$20.18	$20.02	$25.53	-37.85%
October, 2029	$21.32	$19.74	$21.74	-34.34%
November, 2029	$23.26	$20.33	$26.25	-28.36%
December, 2029	$26.20	$21.13	$27.92	-19.30%

Harmony Biosciences Holdings Inc Stock (HRMY) Price Forecast for 2030

Harmony Biosciences Holdings Inc Stock (HRMY) is expected to reach an average price of $25.96 in 2030, with a high forecast of $32.97 and a low forecast of $18.04. This signifies an -20.05% decrease from the last price of $32.47.

Month	Average	Low	High	Change from today's price
January, 2030	$30.21	$26.03	$30.51	-6.98%
February, 2030	$25.93	$25.56	$31.93	-20.15%
March, 2030	$23.49	$22.38	$32.97	-27.66%
April, 2030	$26.07	$22.85	$28.06	-19.71%
May, 2030	$25.63	$22.92	$27.01	-21.06%
June, 2030	$30.51	$24.62	$31.01	-6.02%
July, 2030	$26.06	$25.47	$32.40	-19.73%
August, 2030	$26.82	$23.34	$28.94	-17.41%
September, 2030	$20.04	$18.04	$27.54	-38.29%
October, 2030	$25.66	$19.35	$26.11	-20.97%
November, 2030	$27.24	$24.89	$27.80	-16.10%
December, 2030	$23.84	$22.92	$28.12	-26.57%

Similar to HRMY